You are here: Home » » Story

Ion Exchange launches product for pharma industry

Mumbai : Mumbai-based leading water treatment technnolgy company Ion Exchange (India) Limited has announced the launch of a high-purity water generation product catering to the special needs of the pharmaceutical and biotech industry even as it has shown interest in tapping growing business opportunities as the Centre and states step up focus on sewage treatment around the Ganga.

The launch of Indion Swift 5Gx marks Ion Exchange's expansion of its product line for the pharmaceutical sector within its ‘Indion’ purified water systems range. The company said it has designed the product in consultation with pharmaceutical engineers and end users.

According to the company, Indion Swift 5Gx improves efficiency and purity by introducing a new and unique technology which uses ‘Uniform Particle Size’ resins instead of the conventional resins that are regularly used in water treatment and purification.

The new product uses a short-cycle regeneration method and takes up to 35 minutes only in order to regenerate as compared to other available conventional products that have an average time of eight hours for a single regeneration cycle.

The product is a first of its kind for the pharmaceutical sector and comes with validation package.

“Water is a primary ingredient for pharmaceutical preparations and high purity is an essential factor. Being pioneers in water treatment, Ion Exchange (India) has always invested in R&D to introduce some of the most innovative and technically advanced products and services to meet the needs of the pharma industry’s stringent and critical requirements", said Ion Exchange (India) Limited President Ajay Popat.

"While we have a complete range of high purity water generation and demineralisation products, Indion Swift 5Gx offers latest technology for producing high purity water consistently for the pharmaceutical and biotechnology sectors. The performance driven product is cost effective, modular, energy efficient and has a very short regeneration time of only 35 minutes. This is sure to improve overall productivity for varied pharmaceutical processes", he added.

Indion Swift 5Gx is fully automatic and has minimum bacteria build-up due to its short cycle. The product is also entirely compliant with several specifications and with GAMP & ISPE design standards, the company said.

With the launch, the company is also looking to expand its market share in the industry for water treatment for pharma units. The current industry size is to the tune of Rs 400-500 crore and Ion Exchange (India) reportedly has market share of over 15 per cent.

The new product is expected to improve overall productivity for varied pharmaceutical processes, said Popat.

Ion Exchange is also reportely planning to invest Rs 40-50 crore in expanding resin production capacity in Gujarat plant. The company is a specialist in ion exchange resins used for water applications and non-water applications in pharmaceutical formulations and polymeric adsorbents.

The company is also eyeing wastewater treatment projects in Maharashtra, Tamil Nadu and Karnataka, among others, where municipal agencies are plannting to set up sewage treatment plants (STPs)

"The company is closely following the Namami Gange programme, where nearly 300 STPs would come up in the five states the Ganga flows through, as also another six in Mumbai, tender for which would be out next year. We are also looking at cities like Bengaluru and Chennai", Popat was quoted as saying in a news report.

Nine of the 10 worst global risks are linked to water

Water is one of the world’s gravest risks, according to the Global Risks Report published earlier this week at the World Economic Forum in Davos. And the situation is actually worse than it might seem at first glance.